The first international workshop on the epigenetics of osteoarthritis

Connective Tissue Research

Volumn 58, Issue 1, 2017, Pages 37-48

  Meulenbelt, Ingrid M ^a   Bhutani, Nidhi ^b   den Hollander, Wouter ^a   Gay, Steffen ^c   Oppermann, Udo ^d   Reynard, Louise N ^e   Skelton, Andrew J ^e   Young, David A ^e   Beier, Frank ^f   Loughlin, John ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f WESTERN UNIVERSITY   (Canada)

Author keywords

DNA methylation; epigenetics; histones; osteoarthritis; regulatory RNAs

Indexed keywords

CYTOSINE; RNA; UNTRANSLATED RNA;

ARTICLE; DNA METHYLATION; EPIGENETICS; GENETIC ANALYSIS; HISTONE MODIFICATION; HUMAN; METHYLATION; OSTEOARTHRITIS; PATHOGENESIS; RNA SEQUENCE; WORKSHOP; ANIMAL; DENMARK; ORGANIZATION;

ANIMALS; CONGRESSES AS TOPIC; DENMARK; EPIGENOMICS; HUMANS; OSTEOARTHRITIS;

EID: 84973859792     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2016.1168409     Document Type: Article

References (107)

1. Hunter DJ, Felson DT., Osteoarthritis. Br Med J 2006;332:639–42.
2. Hawker GA, Croxford R, Bierman AS, Harvey PJ, Ravi B, Stanaitis I, Lipscombe LL., All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis:a population based cohort study. PLoS One 2014;9:e91286.
3. Hunter DJ, Schofield D, Callander E., The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 2014;10:437–41.
4. Loeser RF, Goldring SR, Scanzello CR, Goldring MB., Osteoarthritis:a disease of the joint as an organ. Arthritis Rheumatol 2012;64:1697–1707.
5. Fosang AJ, Beier F., Emerging frontiers in cartilage and chondrocyte biology. Best Pract Res Clin Rheumatol 2011;25:751–66.
6. Reynard LN, Loughlin J., Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol 2013;9:573–83.
7. van den Bosch MH, Gleissl TA, Blom AB, van den Berg WB, van Lent PL, van der Kraan PM. Wnts talking with the TGF-β superfamily:WISPers about modulation of osteoarthritis. Rheumatology (Oxford) 2016 (in press).
8. Zengini E, Finan C, Wilkinson JM., The genetic epidemiological landscape of hip and knee osteoarthritis:where are we now and where are we going? J Rheumatol 2016;43:260–6.
9. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S, Fujioka M, Sudo A, Uchida A, Yamamoto S, Ozaki K, Takigawa M, Tanaka T, Nakamura Y, Jiang Q, Ikegawa S., A functional polymorphism in the 5’ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007;39:529–33.
10. Egli R, Southam L, Wilkins JM, Lorenzen I, Pombo-Suarez M, Gonzalez A, Carr A, Chapman K, Loughlin J., Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheumatol 2009;60:2055–64.
11. Bos SD, Bovée JV, Duijnisveld BJ, Raine EV, van Dalen WJ, Ramos YF, van der Breggen R, Nelissen RG, Slagboom PE, Loughlin J, Meulenbelt I., Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 2012;71:1254–8.
12. Styrkarsdottir U, Thorleifsson G, Helgadottir HT, Bomer N, Metrustry S, Bierma-Zeinstra S, Strijbosch AM, Evangelou E, Hart D, Beekman M, Jonasdottir A, Sigurdsson A, Eiriksson FF, Thorsteinsdottir M, Frigge ML, Kong A, Gudjonsson SA, Magnusson OT, Masson G,; TREAT-OA, Consortium; arcOGEN Consortium, Hofman A, Arden NK, Ingvarsson T, Lohmander S, Kloppenburg M, Rivadeneira F, Nelissen RG, Spector T, Uitterlinden A, Slagboom PE, Thorsteinsdottir U, Jonsdottir I, Valdes AM, Meulenbelt I, van Meurs J, Jonsson H, Stefansson K. Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat Genet 2014;46:498–502.
13. Barter MJ, Bui C, Young DA., Epigenetic mechanisms in cartilage and osteoarthritis:DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012;20:339–49.
14. Hashimoto K, Otero M, Imagawa K, de Andrés MC, Coico JM, Roach HI, Oreffo RO, Marcu KB, Goldring MB., Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem 2013;288:10061–72.
15. Le LT, Swingler TE, Clark IM., The role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheumatol 2013;65:1963–74.
16. Crowe N, Swingler TE, Le LT, Barter MJ, Wheeler G, Pais H, Donell ST, Young DA, Dalmay T, Clark IM., Detecting new microRNAs in human osteoarthritic chondrocytes identifies miR-3085 as a human, chondrocyte-selective, microRNA. Osteoarthritis Cartilage 2016;24:534–43.
17. Delgado-Calle J, Fernández AF, Sainz J, Zarrabeitia MT, Sañudo C, García-Renedo R, Pérez-Núñez MI, García-Ibarbia C, Fraga MF, Riancho JA., Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis. Arthritis Rheumatol 2013;65:197–205.
18. Fernández-Tajes J, Soto-Hermida A, Vázquez-Mosquera ME, Cortés-Pereira E, Mosquera A, Fernández-Moreno M, Oreiro N, Fernández-López C, Fernández JL, Rego-Pérez I, Blanco FJ., Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis 2014;73:668–77.
19. den Hollander W, Ramos YF, Bos SD, Bomer N, van der Breggen R, Lakenberg N, de Dijcker WJ, Duijnisveld BJ, Slagboom PE, Nelissen RG, Meulenbelt I., Knee and hip articular cartilage have distinct epigenomic landscapes:implications for future cartilage regeneration approaches. Ann Rheum Dis 2014;73:2208–12.
20. Rushton MD, Reynard LN, Barter MJ, Refaie R, Rankin KS, Young DA, Loughlin J., Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol 2014;66:2450–60.
21. Jeffries MA, Donica M, Baker LW, Stevenson ME, Annan AC, Humphrey MB, James JA, Sawalha AH., Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol 2014;66:2804–15.
22. Moazedi-Fuerst FC, Hofner M, Gruber G, Weinhaeusel A, Stradner MH, Angerer H, Peischler D, Lohberger B, Glehr M, Leithner A, Sonntagbauer M, Graninger WB., Epigenetic differences in human cartilage between mild and severe OA. J Orthop Res 2014;32:1636–45.
23. Rushton MD, Reynard LN, Young DA, Shepherd C, Aubourg G, Gee F, Darlay R, Deehan D, Cordell HJ, Loughlin J., Methylation quantitative trait locus analysis of osteoarthritis links epigenetics with genetic risk. Hum Mol Genet 2015;24:7432–44.
24. den Hollander W, Ramos YF, Bomer N, Elzinga S, van der Breggen R, Lakenberg N, de Dijcker WJ, Suchiman HE, Duijnisveld BJ, Houwing-Duistermaat JJ, Slagboom PE, Bos SD, Nelissen RG, Meulenbelt I., Transcriptional associations of osteoarthritis-mediated loss of epigenetic control in articular cartilage. Arthritis Rheumatol. 2015;67:2108–16.
25. Jaenisch R, Bird A., Epigenetic regulation of gene expression:how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 Suppl:245–54.
26. Bhutani N, Burns DM, Blau HM., DNA demethylation dynamics. Cell 2011;146:866–72.
27. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009;324:930–5.
28. Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y., Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010;466:1129–33.
29. Ito, S., Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011;333:1300–3.
30. Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D, Abramowitz LK, Bartolomei MS, Rambow F, Bassi MR, Bruno T, Fanciulli M, Renner C, Klein-Szanto AJ, Matsumoto Y, Kobi D, Davidson I, Alberti C, Larue L, Bellacosa A., Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011;146:67–79.
31. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011;333:1303–7.
32. Young DA., Editorial:more evidence for a role of CpG methylation in the pathogenesis of osteoarthritis. Arthritis Rheumatol 2013;65,555–8.
33. Cheung KS, Hashimoto K, Yamada N, Roach HI., Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int 2009;29:525–34.
34. Bui, C., Barter MJ, Scott JL, Xu Y, Galler M, Reynard LN, Rowan AD, Young DA. cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J 2012;26:3000–11.
35. Taylor SE, Smeriglio P, Dhulipala L, Rath M, Bhutani N., A global increase in 5-hydroxymethylcytosine levels marks osteoarthritic chondrocytes. Arthritis Rheumatol 2014;66:90–100.
36. Taylor SE, Li YH, Wong WH, Bhutani N., Genome-wide mapping of DNA hydroxymethylation in osteoarthritic chondrocytes. Arthritis Rheumatol 2015;67:2129–40.
37. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A., The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010;5:e8888.
38. Shen L, Song CX, He C, Zhang Y., Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem 2014;83:585–614.
39. Ko M, Rao A., TET2:epigenetic safeguard for HSC. Blood 2011;118,4501–3.
40. Vincent JJ, Huang Y, Chen PY, Feng S, Calvopiña JH, Nee K, Lee SA, Le T, Yoon AJ, Faull K, Fan G, Rao A, Jacobsen SE, Pellegrini M, Clark AT., Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 2013;12:470–8.
41. Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, Street C, Li Y, Poidevin M, Wu H, Gao J, Liu P, Li L, Xu GL, Jin P, He C., Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013;153:678–91.
42. Lu X, Song CX, Szulwach K, Wang Z, Weidenbacher P, Jin P, He C., Chemical modification-assisted bisulfite sequencing (CAB-Seq) for 5-carboxylcytosine detection in DNA. J Am Chem Soc 2013;135,9315–7.
43. Bomer N, den HW, Ramos YF, Bos SD, van der Breggen R, Lakenberg N, Pepers BA, van Eeden AE, Darvishan A, Tobi EW, Duijnisveld BJ, van den Akker EB, Heijmans BT, van Roon-Mom WM, Verbeek FJ, van Osch GJ, Nelissen RG, Slagboom PE, Meulenbelt I., Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis 2015;74:1571–9.
44. Reynard LN, Bui C, Canty-Laird EG, Young DA, Loughlin J., Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011;20:3450–60.
45. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005;102:15785–90.
46. Dejeux E, El abdalaoui H, Gut IG, Tost J. Identification and quantification of differentially methylated loci by pyrosequencing technology. Methods Mol Biol 2009;507:189–205.
47. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM., Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf 2010;11:587.
48. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M., An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57–74.
49. Jenuwein T, Allis CD., Translating the histone code. Science 2001;293:1074–80.
50. Vaissiere T, Sawan C, Herceg Z., Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008:659:40–8.
51. Dawson MA, Kouzarides T., Cancer epigenetics:from mechanism to therapy. Cell 2012;150:12–27.
52. Greer EL, Shi Y., Histone methylation:a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012;13:343–57.
53. Ng SS, Yue WW, Oppermann U, Klose RJ., Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 2009;66:407–22.
54. Oppermann U., Why is epigenetics important in understanding the pathogenesis of inflammatory musculoskeletal diseases? Arthritis Res Ther 2013;15:209.
55. Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J, Bountra C, Brennan PE, Brown PJ, Bunnage ME, Buser-Doepner C, Campbell RM, Carter AJ, Cohen P, Copeland RA, Cravatt B, Dahlin JL, Dhanak D, Edwards AM, Frederiksen M, Frye SV, Gray N, Grimshaw CE, Hepworth D, Howe T, Huber KV, Jin J, Knapp S, Kotz JD, Kruger RG, Lowe D, Mader MM, Marsden B, Mueller-Fahrnow A, Müller S, O’Hagan RC, Overington JP, Owen DR, Rosenberg SH, Roth B, Ross R, Schapira M, Schreiber SL, Shoichet B, Sundström M, Superti-Furga G, Taunton J, Toledo-Sherman L, Walpole C, Walters MA, Willson TM, Workman P, Young RN, Zuercher WJ., The promise and peril of chemical probes. Nat Chem Biol 2015;11:536–41.
56. Pombo A, Dillon N., Three-dimensional genome architecture:players and mechanisms. Nat Rev Mol Cell Biol 2015;16:245–57.
57. Cubeñas-Potts C, Corces VG., Architectural proteins, transcription, and the three-dimensional organization of the genome. FEBS Lett 2015;589:2923–30.
58. Kim S, Yu NK, Kaang BK., CTCF as a multifunctional protein in genome regulation and gene expression. Exp Mol Med 2015;47:e166.
59. Soshnikova N, Montavon T, Leleu M, Galjart N, Duboule D., Functional analysis of CTCF during mammalian limb development. Dev Cell 2010;19:819–30.
60. Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, Horn D, Kayserili H, Opitz JM, Laxova R, Santos-Simarro F, Gilbert-Dussardier B, Wittler L, Borschiwer M, Haas SA, Osterwalder M, Franke M, Timmermann B, Hecht J, Spielmann M, Visel A, Mundlos S., Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 2015;161:1012–25.
61. Watrin E, Kaiser FJ, Wendt KS., Gene regulation and chromatin organization:relevance of cohesin mutations to human disease. Curr Opin Genet Dev 2016;37:59–66.
62. Pitsillides AA, Beier F., Cartilage biology in osteoarthritis-lessons from developmental biology. Nat Rev Rheumatol 2011;7:654–63.
63. de Wit E, de Laat W., A decade of 3C technologies:insights into nuclear organization. Genes Dev 2012;26:11–24.
64. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigó R., The GENCODE v7 catalog of human long noncoding RNAs:analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775–89.
65. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, Takada S, Lotz MK, Ueno-Kudo H, Asahara H., MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010;24:1173–85.
66. Barter MJ, Tselepi M, Gómez R, Woods S, Hui W, Smith GR, Shanley DP, Clark IM, Young DA., Genome-wide microRNA and gene analysis of mesenchymal stem cell chondrogenesis identifies an essential role and multiple targets for miR 140-5p. Stem Cells 2015;33:3266–80.
67. Rinn JL, Chang HY., Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81:145–66.
68. Vance KW, Ponting CP., Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet 2014;30:348–55.
69. Liu Q, Zhang X, Dai L, Hu X, Zhu J, Li L, Zhou C, Ao Y., Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis. Arthritis Rheumatol 2014;66:969–78.
70. Ramos YF, den Hollander W, Bovee JV, Bomer N, van der Breggen R, Lakenberg N, Keurentjes JC, Goeman JJ, Slagboom PE, Nelissen RG, Bos SD, Meulenbelt I., Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study. PLoS One 2014;9:e103056.
71. Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, Zien A, Obermayr F, Zimmer R, Bartnik E., Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheumatol 2006;54:3533–44.
72. Xu Y, Barter MJ, Swan DC, Rankin KS, Rowan AD, Santibanez-Koref M, Loughlin J, Young DA., Identification of the pathogenic pathways in osteoarthritic hip cartilage:commonality and discord between hip and knee OA. Osteoarthritis Cartilage 2012;20:1029–38.
73. Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A, Sittinger M, Ringe J., Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010;18:581–92.
74. Geyer M, Grassel S, Straub RH, Schett G, Dinser R, Grifka J, Gay S, Neumann E, Muller-Ladner U., Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage 2009;17:328–35.
75. Lambert C, Dubuc JE, Montell E, Verges J, Munaut C, Noel A, Henrotin Y., Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol 2014;66:960–8.
76. Remst DF, Blom AB, Vitters EL, Bank RA, van den Berg WB, Blaney Davidson EN, van der Kraan PM. Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis. Arthritis Rheumatol 2014;66:647–56.
77. Ma CH, Lv Q, Cao Y, Wang Q, Zhou XK, Ye BW, Yi CQ., Genes relevant with osteoarthritis by comparison gene expression profiles of synovial membrane of osteoarthritis patients at different stages. Eur Rev Med Pharmacol Sci 2014;18:431–9.
78. Zhang R, Fang H, Chen Y, Shen J, Lu H, Zeng C, Ren J, Zeng H, Li Z, Chen S, Cai D, Zhao Q., Gene expression analyses of subchondral bone in early experimental osteoarthritis by microarray. PLoS One 2012;7:e32356.
79. Chou CH, Wu CC, Song IW, Chuang HP, Lu LS, Chang JH, Kuo SY, Lee CH, Wu JY, Chen YT, Kraus VB, Lee MT., Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther 2013;15:R190.
80. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK., Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015;43:e47.
81. Gautier L, Cope L, Bolstad BM, Irizarry RA., affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307–15.
82. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y., RNA-seq:an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008;18:1509–17.
83. Han Y, Gao S, Muegge K, Zhang W, Zhou B., Advanced applications of RNA sequencing and challenges. Bioinform Biol Insights 2015;9:29–46.
84. Dillies MA, Rau A, Aubert J, Hennequet-Antier C, Jeanmougin M, Servant N, Keime C, Marot G, Castel D, Estelle J, Guernec G, Jagla B, Jouneau L, Laloë D, Le Gall C, Schaëffer B, Le Crom S, Guedj M, Jaffrézic F, French StatOmique Consortium. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform 2013;14:671–83.
85. Del FC, Scalabrin S, Morgante M, Giorgi FM., An extensive evaluation of read trimming effects on Illumina NGS data analysis. PLoS One 2013;8:e85024.
86. Fonseca NA, Marioni J, Brazma A., RNA-Seq gene profiling–a systematic empirical comparison. PLoS One 2014;9:e107026.
87. Li H, Durbin R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754–60.
88. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL., TopHat2:accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013;14:R36.
89. Wu TD, Nacu S., Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010;26:873–81.
90. Langmead B, Salzberg SL., Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012;9:357–9.
91. Castel SE, Levy-Moonshine A, Mohammadi P, Banks E, Lappalainen T., Tools and best practices for data processing in allelic expression analysis. Genome Biol 2015;16:195.
92. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S., Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Path 1996;149:1607–15.
93. Frank-Bertoncelj M, Gay S., The epigenome of synovial fibroblasts:an underestimated therapeutic target in rheumatoid arthritis. Arthritis Res Ther 2014;16:117.
94. Neidhart M, Rethage J, Kuchen S, Künzler P, Crowl RM, Billingham ME, Gay RE, Gay S., Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue:association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheumatol 2000;43:2634–47.
95. Klein K, Gay S., Epigenetics in rheumatoid arthritis. Curr Opin Rheumatol 2015;27:76–82.
96. Karouzakis E, Trenkmann M, Gay RE, Michel BA, Gay S, Neidhart M., Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts. J Immun 2014;193:4945–51.
97. Neidhart M, Karouzakis E, Jüngel A, Gay RE, Gay S., Inhibition of spermidine/spermine N1-acetyltransferase activity:a new therapeutic concept in rheumatoid arthritis. Arthritis Rheumatol 2014;66:1723–33.
98. Klein K, Kabala PA, Grabiec AM, Gay RE, Kolling C, Lin LL, Gay S, Tak PP, Prinjha RK, Ospelt C, Reedquist KA., The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 2016;75:422–9.
99. Ospelt C, Armaka M, Russo G, Bratus A, Trenkmann M, Karouzakis E, Kolling C, Gay RE, Kollias G, Gay S, Frank-Bertoncelj M., Joint specific positional differences in coding and noncoding transcriptome of synovial fibroblasts as a determinant of the susceptibility of synovial joints to rheumatoid arthritis. Arthritis Rheumatol 2014;66:S1216.
100. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D., Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheumatol 2008;58:1001–9.
101. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB., MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011;108:11193–8.
102. Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C, Gay R, Buckley CD, Tak PP, Gay S, Kyburz D., Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheumatol 2011;63:373–81.
103. Brock M, Trenkmann M, Gay RE, Gay S, Speich R, Huber LC., MicroRNA-18a enhances the interleukin-6 mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem 2011;286:40142–50.
104. Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, Huber LC., Tumor necrosis factor α-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-κB signaling. Arthritis Rheumatol 2013;65:916–27.
105. Filkova M, Jüngel A, Gay RE, Gay S., MicroRNAs in rheumatoid arthritis:potential role in diagnosis and therapy. BioDrugs 2012;26:131–41.
106. Brock M, Samillan VJ, Trenkmann M, Schwarzwald C, Ulrich S, Gay RE, Gassmann M, Ostergaard L, Gay S, Speich R, Huber LC., AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur Heart J 2014;35:3203–11.
107. Jeffries MA, Donica M, Baker L, Stevenson M, Annan AC, Humphrey MB, James JA, Sawalha AH., Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic subchondral bone and similarity to overlying cartilage. Arthritis Rheumatol 2016 (in press).